Close Menu
Florida Atlantic University and spinout Cancer Health Solutions Resources are using a $184,000 commercialization-assistance grant from the state to conduct proof-of-concept human clinical trials for a drug against pre-cancerous skin lesions, company and university officials said this week.
 
The gap funding, which has been matched by CHS Resources for a total of $368,000, will also enable the company to continue developing a UV-protective skin lotion based on the same chemicals comprising the drug candidate.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Oil made from gene-edited soybeans is already in use, according to the Associated Press.

USA Today reports that Department of Veterans Affairs is teaming up with Sanford Health to provide veterans with genetic testing.

Mother Jones reports there are few regulations overseeing the use of genetic genealogy by law enforcement.

In Science this week: analysis of ancient DNA recovered from Iberian populations, and more.